搜索临床试验以:Dasatinib Imatinib
总计2065个结果
-
Boehringer Ingelheim完全的
-
Boehringer Ingelheim完全的
-
Boehringer Ingelheim完全的
-
Leiden University Medical CenterBoehringer Ingelheim; Chordoma Foundation主动,不招人
-
Samsung Medical Center完全的
-
Boehringer Ingelheim终止
-
Shandong Cancer Hospital and Institute完全的
-
Tianjin Medical University Cancer Institute and...未知
-
Third Military Medical University未知
-
Peking University People's HospitalPeking University Shougang Hospital完全的
-
M.D. Anderson Cancer CenterElevar Therapeutics尚未招聘
-
Boehringer Ingelheim完全的
-
European Organisation for Research and Treatment...暂停
-
Fudan UniversityJiangsu HengRui Medicine Co., Ltd.完全的
-
Cancer Institute and Hospital, Chinese Academy...尚未招聘
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人根治性切除或消融后复发风险高的肝细胞癌 (HCC) 患者的辅助治疗中国
-
Jiangsu HengRui Medicine Co., Ltd.Peking University Cancer Hospital & Institute完全的
-
Hellenic Cooperative Oncology Group完全的非小细胞肺癌 | EGF-R阳性非小细胞肺癌 | 表皮生长因子受体基因突变
-
Boehringer Ingelheim完全的乳腺肿瘤香港, 台湾, 英国, 俄罗斯联邦, 印度, 波兰
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu Hengrui Pharmaceutical Co., Ltd.招聘中
-
Sichuan Provincial People's HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Michael HoppBoehringer Ingelheim主动,不招人
-
Tetraphase Pharmaceuticals, Inc.PRA Health Sciences完全的
-
Zhengzhou University完全的
-
Yanqiao ZhangJiangsu HengRui Medicine Co., Ltd.未知
-
China International Medical FoundationChinese Society of Clinical Oncology未知
-
Changzhou No.2 People's Hospital未知
-
European Organisation for Research and Treatment...Boehringer Ingelheim完全的